These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23905599)

  • 21. Carotid baroreflex activation therapy for resistant hypertension.
    Victor RG
    Nat Rev Cardiol; 2015 Aug; 12(8):451-63. PubMed ID: 26149485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and chronic electrical activation of baroreceptor afferents in awake and anesthetized subjects.
    Durand MT; Fazan R; Salgado MC; Salgado HC
    Braz J Med Biol Res; 2009 Jan; 42(1):53-60. PubMed ID: 19219297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure.
    Yin D; Slavin KV
    Prog Neurol Surg; 2015; 29():83-93. PubMed ID: 26394178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baroreflex activation for the treatment of hypertension: principles and practice.
    Sica DA; Lohmeier TE
    Expert Rev Med Devices; 2006 Sep; 3(5):595-601. PubMed ID: 17064245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrical carotid sinus stimulation in treatment resistant arterial hypertension.
    Jordan J; Heusser K; Brinkmann J; Tank J
    Auton Neurosci; 2012 Dec; 172(1-2):31-6. PubMed ID: 23146623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T; Scheffers I; De Leeuw PW; Winkens B; Jongen-Vancraybex H; Tordoir JH; Schmidli J; Mohaupt MG; Allemann Y; Kroon AA
    J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.
    Doumas M; Guo D; Papademetriou V
    Expert Opin Ther Targets; 2009 Apr; 13(4):413-25. PubMed ID: 19335064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?
    Doumas M
    Curr Vasc Pharmacol; 2014 Jan; 12(1):2-3. PubMed ID: 23905600
    [No Abstract]   [Full Text] [Related]  

  • 30. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistant hypertension: baroreflex stimulation as a new tool.
    Menne J; Jordan J; Linnenweber-Held S; Haller H
    Nephrol Dial Transplant; 2013 Feb; 28(2):288-95. PubMed ID: 23223217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistant hypertension and carotid baroreceptors stimulation].
    Lantelme P; Harbaoui B; Courand PY
    Presse Med; 2015; 44(7-8):730-6. PubMed ID: 26144275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carotid barostimulation in the treatment of resistant hypertension].
    Rossignol P
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S133-4. PubMed ID: 26972094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
    Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Baroflex stimulation: a novel treatment option for resistant hypertension].
    Eckert S
    MMW Fortschr Med; 2011 Feb; 153(6):49-50. PubMed ID: 21644339
    [No Abstract]   [Full Text] [Related]  

  • 36. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baroreflex activation therapy for patients with drug-resistant hypertension.
    Alnima T; Kroon AA; de Leeuw PW
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):955-62. PubMed ID: 25017430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension.
    Ng MM; Sica DA; Frishman WH
    Cardiol Rev; 2011; 19(2):52-7. PubMed ID: 21285662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baroreflex activation therapy systems: current status and future prospects.
    Seravalle G; Dell'Oro R; Grassi G
    Expert Rev Med Devices; 2019 Dec; 16(12):1025-1033. PubMed ID: 31774336
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel Interventional Therapies to Modulate the Autonomic Tone in Heart Failure.
    Chatterjee NA; Singh JP
    JACC Heart Fail; 2015 Oct; 3(10):786-802. PubMed ID: 26364257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.